Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$8.45 - $12.48 $636,344 - $939,831
75,307 New
75,307 $762,000
Q4 2022

Feb 14, 2023

BUY
$8.57 - $17.0 $124,916 - $247,792
14,576 Added 90.56%
30,671 $287,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $17.54 $202,153 - $282,306
16,095 New
16,095 $234,000
Q1 2022

May 16, 2022

SELL
$11.67 - $26.72 $269,693 - $617,499
-23,110 Closed
0 $0
Q4 2021

Mar 03, 2022

BUY
$13.77 - $42.56 $318,224 - $983,561
23,110 New
23,110 $592,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.